Multi-omics Metabolomics Analysis — Integrating Metabolites with Other Omics Layers
Multi-omics Integration with Metabolomics · Also known as: metabolomics multi-omics integration, integrated metabolomics, multi-omics metabolite profiling, metabolome-centric multi-omics
Multi-omics metabolomics analysis integrates metabolite profiling data — derived from mass spectrometry or NMR spectroscopy — with genomic, transcriptomic, and/or proteomic datasets to build a system-level view of biological phenotypes. By anchoring integration on the metabolome, which reflects the downstream functional output of gene expression and protein activity, this approach connects upstream molecular variation to observable biochemical states, enabling richer mechanistic insight than any single omics layer alone.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
+2 more
When to use it
Use multi-omics metabolomics analysis when you have matched samples profiled on at least two omics platforms, one of which is metabolomics, and your scientific question concerns system-level mechanisms or biomarker panels rather than a single molecular layer. It is especially powerful in disease phenotyping, drug mechanism studies, and nutrition research where metabolites are direct proxies of physiological state. Avoid this approach when sample sizes are small (fewer than ~30 matched samples per group), when metabolomics data quality is poor or batch effects cannot be resolved, when only one omics layer is available, or when the research question is adequately answered by differential expression alone. Integrating low-quality data amplifies noise and can produce spurious cross-omics correlations.
Strengths & limitations
- Captures the full molecular cascade from genotype to phenotype by linking upstream genetic and transcriptomic variation to downstream metabolic outputs.
- Metabolites provide functional, biochemically interpretable endpoints that translate more directly to clinical phenotypes than gene expression alone.
- Pathway-level integration reduces the multiple-testing burden and focuses statistical power on biologically coherent signals.
- Flexible architecture supports pairwise (two-layer) or higher-order (three or more layers) integration as data availability grows.
- Enables discovery of causal or regulatory relationships between omics layers via mediation analysis or Mendelian randomization frameworks.
- Requires large, matched sample cohorts profiled on multiple platforms, making data collection expensive and logistically complex.
- Metabolomics data suffer from high missingness rates, batch effects, and platform-specific coverage gaps that are harder to harmonize than RNA-seq data.
- Integration methods differ substantially in assumptions; results can be sensitive to the chosen algorithm, and consensus across methods is rarely reported.
- Biological interpretation of cross-omics correlations is not straightforward — correlation does not establish directionality or causation without additional experimental or genetic evidence.
- Computational pipelines are non-trivial to implement reproducibly; lack of standardized workflows makes cross-study comparisons difficult.
Frequently asked
What is the minimum sample size needed for multi-omics metabolomics integration?
There is no universal threshold, but most methodologists recommend at least 30 samples per group for pairwise correlation-based integration and substantially more (100+) for latent-factor methods such as MOFA or for mQTL mapping. Small samples produce high variance in cross-omics correlations; simulations show that with fewer than 20 samples per group, spurious correlations are common even at stringent significance cutoffs.
Should I correct batch effects before or after integration?
Always correct batch effects within each omics layer independently before integration. Applying batch correction after merging layers conflates biological cross-omics variation with technical variation, and most batch-correction algorithms are designed for a single data type. Use ComBat or LOESS for metabolomics; Combat-seq or RUVseq for RNA-seq; then integrate the corrected matrices.
What is the difference between early, late, and intermediate integration?
Early integration concatenates all omics feature matrices before modeling; it is simple but noisy when features vastly differ in scale. Late integration analyzes each omics layer separately and then combines results (e.g., by meta-analysis or intersection of significant features); it is robust but loses cross-layer synergy. Intermediate (mixed) integration — as in MOFA or SNF — models shared latent structure across layers simultaneously and is generally preferred for discovery.
Do metabolites need to be identified for integration, or can I use unknown features?
Integration can be performed on unidentified mass-spectral features (peaks), but pathway-level biological interpretation requires at minimum putative metabolite identifications (Level 2 in the Metabolomics Standards Initiative hierarchy). Unknown features contribute to statistical integration and clustering but cannot be meaningfully mapped to KEGG or Reactome pathways. Reporting the identification level for each metabolite is a community standard.
How is multi-omics metabolomics different from metabolomics alone?
Metabolomics alone identifies differences in metabolite abundance between conditions but cannot easily distinguish whether those differences arise from altered gene expression, enzyme activity, substrate availability, or environmental factors. Multi-omics integration adds genomic and transcriptomic context that allows researchers to trace the source of metabolic variation up the molecular cascade and to identify which regulatory mechanisms are most likely causal.
Sources
- Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020). Multi-omics data integration, interpretation, and its application. Bioinformatics and Biology Insights, 14, 1177932219899051. link ↗
- Hasin, Y., Seldin, M., & Lusis, A. (2017). Multi-omics approaches to disease. Genome Biology, 18(1), 83. link ↗
How to cite this page
ScholarGate. (2026, June 3). Multi-omics Integration with Metabolomics. ScholarGate. https://scholargate.app/en/bioinformatics/multi-omics-metabolomics-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Metabolomics analysisBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- Proteomics AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare